GW Pharma (GWPH) Reports Q2 Revenue of $4.6M, Tops Consensus by~$2M

GW Pharma (NASDAQ: GWPH) reported Q2 EPS of $. Revenue for the quarter came in at $4.6 million versus the consensus estimate of $2.62 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
• HP Inc. (HPQ) Tops Q3 EPS by 17c, Beats on Revenue; Offers FY Guidance
• Bath & Body Works, Inc. (BBWI) Tops Q2 EPS by 38c, Offers FY27 EPS Guidance